Gene · 3455
Papers3,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessment of ubiquitin specific Peptidase-18 gene in peripheral blood of chronic hepatitis C patients treated with direct-acting antiviral drugs. | Heliyon | 2024 | 38298711 | PubTator, text mining | PubMed |
| Proline Metabolism in WHO G4 Gliomas Is Altered as Compared to Unaffected Brain Tissue. | Cancers (Basel) | 2024 | 38275897 | PubTator, text mining | PubMed |
| Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease. | BMC Immunol | 2024 | 38273260 | PubTator, text mining | PubMed |
| The population context is a driver of the heterogeneous response of epithelial cells to interferons. | Mol Syst Biol | 2024 | 38273161 | PubTator, text mining | PubMed |
| Predicting Alu exonization in the human genome with a deep learning model. | bioRxiv | 2024 | 38260329 | PubTator, text mining | PubMed |
| Regulatory Non-Coding RNAs during Porcine Viral Infections: Potential Targets for Antiviral Therapy. | Viruses | 2024 | 38257818 | PubTator, text mining | PubMed |
| Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy. | Int J Mol Sci | 2024 | 38256250 | PubTator, text mining | PubMed |
Transforming Growth Factor Beta 2 (TGFB2) and Interferon Gamma Receptor 2 (IFNGR2) mRNA Levels in the Brainstem Tumor Microenvironment (TME) Significantly Impact Overall Survival in Pediatric DMG Patients. | Biomedicines | 2024 | 38255296 | PubTator, text mining | PubMed |
| The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: A global review. | J Clin Lab Anal | 2024 | 38251811 | PubTator, text mining | PubMed |
| Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration. | Cells | 2024 | 38247815 | PubTator, text mining | PubMed |
| Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‑19 (Review). | Mol Med Rep | 2024 | 38240082 | PubTator, text mining | PubMed |
| Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19. | J Clin Immunol | 2024 | 38231281 | PubTator, text mining | PubMed |
| Human genetic determinants of COVID-19 in Brazil: challenges and future plans. | Genet Mol Biol | 2024 | 38226654 | PubTator, text mining | PubMed |
| Shorter antitubercular therapy for extrapulmonary tuberculosis - a case report. | BMC Infect Dis | 2024 | 38225554 | PubTator, text mining | PubMed |
| Epigenetic addition of m5C to HBV transcripts promotes viral replication and evasion of innate antiviral responses. | Cell Death Dis | 2024 | 38216565 | PubTator, text mining | PubMed |
| Genetic regions affecting the replication and pathogenicity of dengue virus type 2. | PLoS Negl Trop Dis | 2024 | 38190404 | PubTator, text mining | PubMed |
| Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learning. | Commun Biol | 2024 | 38182876 | PubTator, text mining | PubMed |
| Integrated analysis of miRNA-mRNA expression of newly emerging swine H3N2 influenza virus cross-species infection with tree shrews. | Virol J | 2024 | 38178220 | PubTator, text mining | PubMed |
| The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention. | Int J Biol Sci | 2024 | 38164186 | PubTator, text mining | PubMed |
| Refractory dermatomyositis responsive to anifrolumab. | JAAD Case Rep | 2024 | 38162409 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3455/papers?page=9